Malay Shah — University of Kentucky

If you made any changes in Pure these will be visible here soon.

Education/Academic qualification

Residency, Medical College Of Georgia

2009

Doctor of Medicine, MEDICAL COLLEGE OF OHIO

2003

Bachelor of Arts, Univ Of Cincinnati

1999

8 Finished

Technology Enabled And Molecular Monitoring of the Allograft and Transplant rEcipient
Shah, M.
CareDx Incorporated
10/1/21 → 8/7/23
Project: Research project
A Randomized, Double Blind Multicenter Phase 3 Study of the Efficacy, Safety, and Tolerability of 28 Weeks of Brincidofovir vs Valganciclovir for the Precention of Cytomegalovirus Disease in High Risk Kidney Allograft Recipients (303)
Shah, M.
Chimerix Incorporated
7/25/16 → 9/6/16
Project: Research project
A Randomized, Double Blind, Multicenter, Phase 3 Study of Efficacy, Safety, and Tolerability of Brincidofovir vs Valganciclovir for the Prevention of Cytomegalovirus Disease in CMV-Seropositive Kidney Transplant Recipients who Recieved Antilymphocyte Indu
Shah, M.
Chimerix Incorporated
7/25/16 → 9/6/16
Project: Research project
Alexion Eculizumab - A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Multi-Center Study of Eculizumab for the Prevention of Delayed Graft Function After Kidney Transplantation in Adult Subjects at Increased Risk of Delayed Graft Function
Shah, M.
CTI Clinical Trial and Consulting Services
9/25/14 → 8/30/16
Project: Research project
CMV Vaccine-A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial to Evaluate the Efficacy and Safety of a Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seronegative Kidney Transplant Recipients Receiving an Organ from a CMV-Seropositive Donor
Shah, M., Castellanos, A., Daily, M., Rojas, H., Sitzlar, S., Waid, T. & Clifford, T.
Astellas Pharma Global Development Incorporated
4/8/14 → 5/27/21
Project: Research project